NCT01815684View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

PharmacokineticsPharmacodynamicsHealthy SubjectsSafety

Interventions

DRUG

ASP3652

Oral

DRUG

Placebo

Oral

Trial Locations (1)

2333CL

Centre for Human Drug Research, Leiden

All Listed Sponsors

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01815684 - A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects | Biotech Hunter | Biotech Hunter